House Republicans are advancing a budget reconciliation bill with $700 billion in Medicaid savings, but still undecided is what year work requirements would begin.

Some are criticizing Biden’s team for not testing him earlier for prostate cancer. But overtesting is a particular concern ...

President Trump’s science adviser called for a return to reproducible and transparent research to kickstart stalled ...

The past month has been a disastrous chain of events for UnitedHealth Group — which up until recently was a beloved stock on ...

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

While the ACIP made six recommendations in April, Kennedy has only endorsed three so far; they outline who can use newly licensed chikungunya vaccines. Three others, related to a new meningococcal ...

Health insurers continue to use algorithms to predict how long patients need intense care — and thus how much care is covered ...

The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do ...

Regeneron plans to buy 23andMe out of bankruptcy for $256 million, potentially bringing to a close the saga of the consumer ...

The grant termination letters say there are no appeals. Yet dozens of appeals have succeeded as biomedical researchers lobby ...

No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...